Shukla Bindesh Kumar, Yadava Umesh
Department of Physics, SGS PG College, Ganj Basoda, Vidisha, 464221, India.
Department of Physics, DDU Gorakhpur University, Gorakhpur, 273009, India.
Heliyon. 2020 Jun 27;6(6):e04176. doi: 10.1016/j.heliyon.2020.e04176. eCollection 2020 Jun.
An exhaustive quantum mechanical calculations on a pharmaceutically critical molecule N-{4-[(4-amino-3-phenyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)sulfonyl]phenyl}acetamide have been investigated through the B3LYP/6-31G∗∗ Density Functional and HF/6-31G∗∗ Wave Function techniques. Physicochemical parameters along with the advanced electronic structure parameters like; MEP (molecular electrostatic potentials) and highest occupied & lowest unoccupied molecular orbitals (HOMO-LUMO) analysis have additionally been scanned over both methods. The computed HOMO-LUMO energy demonstrates that charge exchange takes place inside the molecule. The estimated small HOMO-LUMO energy gap, through both methods, indicates that the molecule is chemically reactive. Further, the IR vibrational spectra of the molecule have been assigned in the region 400-4000 cm through the DFT technique. The anticipated vibrational assignments have been compared with the experimental values accounted for in the literature. To comprehend the mode of binding, docking investigations of the molecule alongwith the co-crystallized metronidazole (MNZ) molecule were accomplished with O-acetyl-serine-sulfhydrylase (OASS) enzyme using GLIDE-SP and GLIDE-XP modules. Docking simulations and reported biological activities (IC50) demonstrate that the title molecule may act as a lead molecule for constraining the progression of illness.
通过B3LYP/6-31G密度泛函和HF/6-31G波函数技术,对一种药学关键分子N-{4-[(4-氨基-3-苯基-1H-吡唑并[3,4-d]嘧啶-1-基)磺酰基]苯基}乙酰胺进行了详尽的量子力学计算。还通过这两种方法扫描了物理化学参数以及诸如分子静电势(MEP)和最高占据分子轨道与最低未占据分子轨道(HOMO-LUMO)分析等先进的电子结构参数。计算得到的HOMO-LUMO能量表明分子内部发生了电荷交换。通过这两种方法估计的较小的HOMO-LUMO能隙表明该分子具有化学反应活性。此外,通过DFT技术在400-4000 cm区域内对该分子的红外振动光谱进行了归属。将预期的振动归属与文献中报道的实验值进行了比较。为了理解结合模式,使用GLIDE-SP和GLIDE-XP模块,将该分子与共结晶的甲硝唑(MNZ)分子一起与O-乙酰丝氨酸巯基酶(OASS)进行对接研究。对接模拟和报道的生物活性(IC50)表明,该标题分子可能作为一种先导分子来抑制疾病的进展。